{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:23:25Z","timestamp":1793085805200,"version":"4.5.0"},"reference-count":210,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s13311-019-00822-4","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T09:59:29Z","timestamp":1580723969000},"page":"105-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Intranasal Insulin: a Treatment Strategy for Addiction"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4823-9638","authenticated-orcid":false,"given":"Bhavani","family":"Kashyap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frey II","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-019-00822-4_bib1","unstructured":"Abuse S. Mental Health Services Administration (2018). Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Rockville, MD: Center for Behavioral Health Statistics and Quality. Substance Abuse and Mental Health Services Administration Retrieved from https:\/\/www samhsa gov\/data. 2018."},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.mcna.2016.03.011","article-title":"Pharmacotherapy for Substance Use Disorders","volume":"100","author":"Klein","year":"2016","journal-title":"Med Clin N Am"},{"issue":"10200","key":"10.1007\/s13311-019-00822-4_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(19)31775-1","article-title":"Alcohol use disorders","volume":"394","author":"Carvalho","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1007\/s13311-019-00822-4_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review","volume":"320","author":"Kranzler","year":"2018","journal-title":"Jama."},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/HRP.0000000000000079","article-title":"Pharmacotherapy for alcohol use disorder: current and emerging therapies","volume":"23","author":"Swift","year":"2015","journal-title":"Harv Rev Psychiatry"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14740338.2018.1404025","article-title":"Alcohol addiction - the safety of available approved treatment options","volume":"17","author":"Antonelli","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"10.1007\/s13311-019-00822-4_bib7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/14656566.2017.1349098","article-title":"Pharmacotherapy of alcoholism - an update on approved and off-label medications","volume":"18","author":"Soyka","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"17","key":"10.1007\/s13311-019-00822-4_bib8","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1080\/14656566.2016.1244529","article-title":"Update on pharmacotherapy for treatment of opioid use disorder","volume":"17","author":"Ayanga","year":"2016","journal-title":"Expert Opin Pharmacother"},{"issue":"18","key":"10.1007\/s13311-019-00822-4_bib9","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1080\/14656566.2017.1409722","article-title":"Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus","volume":"18","author":"Dematteis","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and Treatment of Opioid Misuse and Addiction: A Review","volume":"76","author":"Volkow","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s13181-015-0517-5","article-title":"Pharmacotherapy of Opioid Addiction: \u201cPutting a Real Face on a False Demon\u201d","volume":"12","author":"Salsitz","year":"2016","journal-title":"J Med Toxicol"},{"key":"10.1007\/s13311-019-00822-4_bib12","doi-asserted-by":"crossref","unstructured":"Fields JB, Dabam III WF, Dfasam D, Wilford BB. Opioid Pharmacotherapies for Substance Use Disorders and Addiction. The American Society of Addiction Medicine Handbook on Pain and Addiction 2018:221.","DOI":"10.1093\/med\/9780190265366.003.0019"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib13","first-page":"305","article-title":"Pharmacological treatments for methamphetamine addiction: current status and future directions","volume":"10","author":"Ballester","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1007\/s13311-019-00822-4_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3389\/fpsyt.2019.00509","article-title":"Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits","volume":"10","author":"D'Souza","year":"2019","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2014.01.008","article-title":"Impulsivity as a vulnerability factor for poor addiction treatment outcomes: a review of neurocognitive findings among individuals with substance use disorders","volume":"47","author":"Stevens","year":"2014","journal-title":"J Subst Abus Treat"},{"key":"10.1007\/s13311-019-00822-4_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuropharm.2014.05.011","article-title":"Neural correlates of craving and impulsivity in abstinent former cocaine users: Towards biomarkers of relapse risk","volume":"85","author":"Bell","year":"2014","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-019-00822-4_bib17","doi-asserted-by":"crossref","unstructured":"D'Souza MS, Markou A. Neural substrates of psychostimulant withdrawal-induced anhedonia. Behav Neurosci Drug Addict: Springer; 2010. p. 119-78.","DOI":"10.1007\/7854_2009_20"},{"key":"10.1007\/s13311-019-00822-4_bib18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.neubiorev.2016.09.030","article-title":"Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways","volume":"71","author":"Dom\u00ednguez-Salas","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1007\/s13311-019-00822-4_bib19","unstructured":"Frey WH, II, inventor; Ramsey Foundation, St. Paul, Minn., assignee. Neurolic Agents for Nasal Administration to the Brain. PCT\/US patent WO1991007947A1. 1991 13.06.1991."},{"key":"10.1007\/s13311-019-00822-4_bib20","unstructured":"Frey WH, II, inventor; Chiron Corporation, assignee. Method for Administering Neurologic Agents to the Brain. US patent 6,180,603. 2001 Jan 30 2001."},{"key":"10.1007\/s13311-019-00822-4_bib21","unstructured":"Frey WH, II, inventor; Ramsey Foundation, St. Paul, Minn., assignee. Method of Administering Neurologic Agents to the Brain. US patent 5,624,898. 1997 Apr 29, 1997."},{"key":"10.1007\/s13311-019-00822-4_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187221108783331429","article-title":"Recent patents review on intranasal administration for CNS drug delivery","volume":"2","author":"Jogani","year":"2008","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"10.1007\/s13311-019-00822-4_bib24","unstructured":"Frey WH, II, inventor; Chiron Corporation, assignee. Method for Administering Insulin to the Brain. US patent 6,313,093 B1 2001 Nov 6, 2001."},{"issue":"1-2","key":"10.1007\/s13311-019-00822-4_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","article-title":"Quantitative analysis of the olfactory pathway for drug delivery to the brain","volume":"692","author":"Thorne","year":"1995","journal-title":"Brain Res"},{"issue":"8 Pt 1","key":"10.1007\/s13311-019-00822-4_bib26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0895-7061(98)00095-8","article-title":"Intranasal angiotensin II directly influences central nervous regulation of blood pressure","volume":"11","author":"Derad","year":"1998","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1007\/s13311-019-00822-4_bib27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience."},{"key":"10.1007\/s13311-019-00822-4_bib29","unstructured":"Dhanda DS. Approaches for Drug Deposition in the Human Olfactory Epthelium. Drug Deliv Tech 2005."},{"issue":"7","key":"10.1007\/s13311-019-00822-4_bib30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0306-4530(99)00027-X","article-title":"Sleep and endocrine changes after intranasal administration of growth hormone-releasing hormone in young and aged humans","volume":"24","author":"Perras","year":"1999","journal-title":"Psychoneuroendocrinology."},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib31","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1208\/pt0804081","article-title":"Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination","volume":"8","author":"Garmise","year":"2007","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000127187","article-title":"Evidence for central nervous effects of corticotropin-releasing hormone on gastric acid secretion in humans","volume":"65","author":"Kern","year":"1997","journal-title":"Neuroendocrinology."},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib33","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jcbfm.2014.215","article-title":"Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration","volume":"35","author":"Lochhead","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"10.1007\/s13311-019-00822-4_bib35","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-1998-1102","article-title":"Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway","volume":"1","author":"Chen","year":"1998","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymgme.2012.02.006","article-title":"Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration","volume":"106","author":"Wolf","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"Suppl 3","key":"10.1007\/s13311-019-00822-4_bib38","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci"},{"issue":"7","key":"10.1007\/s13311-019-00822-4_bib39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/hum.2017.187","article-title":"Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I","volume":"28","author":"Belur","year":"2017","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2010.1130","article-title":"Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease","volume":"14","author":"Danielyan","year":"2011","journal-title":"Rejuvenation Res"},{"issue":"6","key":"10.1007\/s13311-019-00822-4_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","article-title":"Intranasal delivery of cells to the brain","volume":"88","author":"Danielyan","year":"2009","journal-title":"Eur J Cell Biol"},{"key":"10.1007\/s13311-019-00822-4_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-2094-9-112","article-title":"CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery","volume":"9","author":"Fransson","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"Suppl 1","key":"10.1007\/s13311-019-00822-4_bib43","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.3727\/096368914X684970","article-title":"Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease","volume":"23","author":"Danielyan","year":"2014","journal-title":"Cell Transplant"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00221-012-3101-0","article-title":"Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice","volume":"219","author":"Fine","year":"2012","journal-title":"Exp Brain Res"},{"key":"10.1007\/s13311-019-00822-4_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2014.05.048","article-title":"Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinsons disease","volume":"1574","author":"Fine","year":"2014","journal-title":"Brain Res"},{"key":"10.1007\/s13311-019-00822-4_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10717549709051878","article-title":"Delivery of 125I-NGF to the Brain via the Olfactory Route","volume":"4","author":"Frey","year":"1997","journal-title":"Drug Deliv"},{"issue":"7","key":"10.1007\/s13311-019-00822-4_bib47","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/NMD.0b013e318298302e","article-title":"Intranasal insulin to treat and protect against posttraumatic stress disorder","volume":"201","author":"Frey","year":"2013","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib48","first-page":"39","article-title":"Intranasal Delivery of Stem Cells & Genetically Engineered Cells to the Brain","volume":"10","author":"Frey","year":"2010","journal-title":"Drug Deliv Tech"},{"key":"10.1007\/s13311-019-00822-4_bib49","doi-asserted-by":"crossref","unstructured":"Hanson L, Fine J, Renner D, Svitak A, Burns R, Nguyen T, et al. Intranasal delivery of deferoxamine reduces spatial memory loss in APP\/PS1 mice. Drug Deliv Transl Res 2012:1-9.","DOI":"10.1007\/s13346-011-0050-2"},{"key":"10.1007\/s13311-019-00822-4_bib50","doi-asserted-by":"crossref","unstructured":"Hanson LR, Fine JM, Hoekman JD, Nguyen TM, Burns RB, Martinez PM, et al. Intranasal delivery of growth differentiation factor 5 to the central nervous system. Drug delivery. 2012.","DOI":"10.3109\/10717544.2012.657720"},{"key":"10.1007\/s13311-019-00822-4_bib51","doi-asserted-by":"crossref","unstructured":"Hanson LR, Fine JM, Svitak AL, Faltesek KA. Intranasal administration of CNS therapeutics to awake mice. J Vis Exp 2013(74).","DOI":"10.3791\/4440-v"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11481-006-9039-x","article-title":"Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS","volume":"2","author":"Hanson","year":"2007","journal-title":"J NeuroImmune Pharmacol"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib53","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12031-010-9460-8","article-title":"Intranasal phosphoramidon increases beta-amyloid levels in wild-type and NEP\/NEP2-deficient mice","volume":"43","author":"Hanson","year":"2011","journal-title":"J Mol Neurosci"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib54","first-page":"81","article-title":"Intranasal Administration of Hypocretin 1 (Orexin A) Bypasses the Blood-Brain Barrier & Targets the Brain: A New Strategy for the Treatment of Narcolepsy","volume":"4","author":"Hanson","year":"2004","journal-title":"Drug Deliv Tech."},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib55","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/mp100029t","article-title":"Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures","volume":"7","author":"Johnson","year":"2010","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2012.02.037","article-title":"Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway","volume":"513","author":"Renner","year":"2012","journal-title":"Neurosci Lett"},{"issue":"7","key":"10.1007\/s13311-019-00822-4_bib57","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/dom.13279","article-title":"Safety of intranasal human insulin: A review","volume":"20","author":"Schmid","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib58","doi-asserted-by":"crossref","first-page":"e0214364","DOI":"10.1371\/journal.pone.0214364","article-title":"Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study","volume":"14","author":"Novak","year":"2019","journal-title":"PLoS One"},{"key":"10.1007\/s13311-019-00822-4_bib59","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer's disease: current knowledge","volume":"9","author":"Bedse","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1007\/s13311-019-00822-4_bib60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroimage.2019.03.050","article-title":"Modulation of midbrain neurocircuitry by intranasal insulin","volume":"194","author":"Edwin Thanarajah","year":"2019","journal-title":"Neuroimage."},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib61","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000106378","article-title":"Intranasal insulin to improve memory function in humans","volume":"86","author":"Benedict","year":"2007","journal-title":"Neuroendocrinology."},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib62","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-019-00822-4_bib64","doi-asserted-by":"crossref","unstructured":"Freiherr J, Hallschmid M, Frey WH, 2nd, Brunner YF, Chapman CD, Holscher C, et al. Intranasal Insulin as a Treatment for Alzheimer's Disease: A Review of Basic Research and Clinical Evidence. CNS Drugs. 2013.","DOI":"10.1007\/s40263-013-0076-8"},{"key":"10.1007\/s13311-019-00822-4_bib65","doi-asserted-by":"crossref","unstructured":"Lu J, Xu Z. Efficacy of Intranasal Insulin in Improving Cognition in Mild Cognitive Impairment and Alzheimer Disease A systematic Review and Meta-Analysis. Am J Ther 2019.","DOI":"10.1097\/MJT.0000000000000926"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib66","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/jc.2011-1802","article-title":"Effect of intranasal insulin on cognitive function: a systematic review","volume":"97","author":"Shemesh","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib67","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3233\/JAD-190280","article-title":"Intranasal Insulin Increases Synaptic Protein Expression and Prevents Anesthesia-Induced Cognitive Deficits Through mTOR-eEF2 Pathway","volume":"70","author":"Yu","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"10.1007\/s13311-019-00822-4_bib68","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s40263-014-0214-y","article-title":"A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild\u2013moderate Alzheimer's disease","volume":"28","author":"Rosenbloom","year":"2014","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1007\/s13311-019-00822-4_bib69","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology."},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib70","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-019-00822-4_bib71","doi-asserted-by":"crossref","unstructured":"Santiago JC, Hallschmid M. Outcomes and clinical implications of intranasal insulin administration to the central nervous system. Exp Neurol 2019.","DOI":"10.1016\/j.expneurol.2019.03.007"},{"issue":"11","key":"10.1007\/s13311-019-00822-4_bib72","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.2337\/diabetes.53.11.3024","article-title":"Intranasal insulin reduces body fat in men but not in women","volume":"53","author":"Hallschmid","year":"2004","journal-title":"Diabetes."},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib73","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2337\/db11-1390","article-title":"Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women","volume":"61","author":"Hallschmid","year":"2012","journal-title":"Diabetes."},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib74","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1210\/jc.2009-1677","article-title":"Insulin modulates food-related activity in the central nervous system","volume":"95","author":"Guthoff","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib75","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000341406","article-title":"Intranasal insulin modulates intrinsic reward and prefrontal circuitry of the human brain in lean women","volume":"97","author":"Kullmann","year":"2013","journal-title":"Neuroendocrinology."},{"issue":"6","key":"10.1007\/s13311-019-00822-4_bib76","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2337\/dc14-2319","article-title":"Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults","volume":"38","author":"Kullmann","year":"2015","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1007\/s13311-019-00822-4_bib77","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hbm.22304","article-title":"Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation","volume":"35","author":"Schilling","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"10.1007\/s13311-019-00822-4_bib78","doi-asserted-by":"crossref","first-page":"16052","DOI":"10.1038\/ncomms16052","article-title":"Central insulin modulates food valuation via mesolimbic pathways","volume":"8","author":"Tiedemann","year":"2017","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-019-00822-4_bib79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnins.2017.00054","article-title":"Central Nervous Insulin Administration before Nocturnal Sleep Decreases Breakfast Intake in Healthy Young and Elderly Subjects","volume":"11","author":"Santiago","year":"2017","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib80","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-150307","article-title":"Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition","volume":"47","author":"Salameh","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-019-00822-4_bib81","doi-asserted-by":"crossref","unstructured":"Schmid V, Kullmann S, Gfr\u00f6rer W, Hund V, Hallschmid M, Lipp HP, et al. Safety of intranasal human insulin: A review. Diabetes Obes Metab. 2018.","DOI":"10.1111\/dom.13279"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib82","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/jc.2017-01976","article-title":"Dose-Dependent Effects of Intranasal Insulin on Resting-State Brain Activity","volume":"103","author":"Kullmann","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s13311-019-00822-4_bib83","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1360-0443.2006.01586.x","article-title":"The neurobiology of addiction: a neuroadaptational view relevant for diagnosis","volume":"101","author":"Koob","year":"2006","journal-title":"Addiction."},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1176\/foc.9.1.foc55","article-title":"Neurobiology of addiction","volume":"9","author":"Koob","year":"2011","journal-title":"Focus."},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1007\/s13311-019-00822-4_bib86","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/nn1105-1442","article-title":"Plasticity of reward neurocircuitry and the'dark side'of drug addiction","volume":"8","author":"Koob","year":"2005","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib87","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0896-6273(00)80557-7","article-title":"Neuroscience of addiction","volume":"21","author":"Koob","year":"1998","journal-title":"Neuron."},{"issue":"8","key":"10.1007\/s13311-019-00822-4_bib88","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib89","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"issue":"1-2","key":"10.1007\/s13311-019-00822-4_bib90","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0303-7207(01)00455-5","article-title":"Role of insulin and insulin receptor in learning and memory","volume":"177","author":"Zhao","year":"2001","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10.1007\/s13311-019-00822-4_bib91","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0149-7634(00)00040-3","article-title":"Insulin receptors and insulin action in the brain: review and clinical implications","volume":"24","author":"Schulingkamp","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pneurobio.2006.06.003","article-title":"Insulin signaling in the central nervous system: learning to survive","volume":"79","author":"van der Heide","year":"2006","journal-title":"Prog Neurobiol"},{"issue":"4-5","key":"10.1007\/s13311-019-00822-4_bib93","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease","volume":"105","author":"Fr\u00f6lich","year":"1998","journal-title":"J Neural Transm"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib94","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000054345","article-title":"Food deprivation decreases mRNA and activity of the rat dopamine transporter","volume":"68","author":"Patterson","year":"1998","journal-title":"Neuroendocrinology."},{"issue":"5","key":"10.1007\/s13311-019-00822-4_bib95","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1471-4159.2005.03289.x","article-title":"Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine","volume":"94","author":"Owens","year":"2005","journal-title":"J Neurochem"},{"issue":"10","key":"10.1007\/s13311-019-00822-4_bib96","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1371\/journal.pbio.0050274","article-title":"Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine","volume":"5","author":"Williams","year":"2007","journal-title":"PLoS Biol"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib97","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bbrc.2008.05.091","article-title":"PI3K signaling supports amphetamine-induced dopamine efflux","volume":"372","author":"Lute","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib98","first-page":"R9","article-title":"Insulin, leptin, and food reward: update 2008","volume":"296","author":"Figlewicz","year":"2009","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"6566","key":"10.1007\/s13311-019-00822-4_bib99","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature."},{"issue":"1-3","key":"10.1007\/s13311-019-00822-4_bib100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","article-title":"Monoamine transporters and psychostimulant drugs","volume":"479","author":"Rothman","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib101","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1371\/journal.pbio.0020078","article-title":"N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux","volume":"2","author":"Khoshbouei","year":"2004","journal-title":"PLoS Biol"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib102","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1523\/JNEUROSCI.3779-10.2011","article-title":"Insulin Modulates Cocaine-Sensitive Monoamine Transporter Function and Impulsive Behavior","volume":"31","author":"Schoffelmeer","year":"2011","journal-title":"J Neurosci"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145705005481","article-title":"Positive association of AKT1 haplotype to Japanese methamphetamine use disorder","volume":"9","author":"Ikeda","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib104","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia","volume":"36","author":"Emamian","year":"2004","journal-title":"Nat Genet"},{"issue":"8","key":"10.1007\/s13311-019-00822-4_bib105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tins.2007.06.004","article-title":"Is dopamine a physiologically relevant mediator of feeding behavior?","volume":"30","author":"Palmiter","year":"2007","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib106","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pbb.2010.03.002","article-title":"Energy regulatory signals and food reward","volume":"97","author":"Figlewicz","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"10.1007\/s13311-019-00822-4_bib107","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.physbeh.2006.10.008","article-title":"Modulation of food reward by adiposity signals","volume":"91","author":"Figlewicz","year":"2007","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib108","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1460-9568.2012.08168.x","article-title":"Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake","volume":"36","author":"Mebel","year":"2012","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib109","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbr.2011.01.020","article-title":"Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats","volume":"219","author":"Bruijnzeel","year":"2011","journal-title":"Behav Brain Res"},{"issue":"11","key":"10.1007\/s13311-019-00822-4_bib110","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrn3105","article-title":"Common cellular and molecular mechanisms in obesity and drug addiction","volume":"12","author":"Kenny","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib111","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1210\/jc.2007-2606","article-title":"Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin","volume":"93","author":"Benedict","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib112","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI117703","article-title":"Evidence that the brain of the conscious dog is insulin sensitive","volume":"95","author":"Davis","year":"1995","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib113","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/ejn.14291","article-title":"Insulin in the ventral tegmental area reduces cocaine-evoked dopamine in the nucleus accumbens in vivo","volume":"50","author":"Naef","year":"2019","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib114","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00001756-199310000-00014","article-title":"Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system","volume":"5","author":"Beitner-Johnson","year":"1993","journal-title":"Neuroreport."},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib115","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1046\/j.1471-4159.1999.0731520.x","article-title":"Regulation of phospholipase C\u03b3 in the mesolimbic dopamine system by chronic morphine administration","volume":"73","author":"Wolf","year":"1999","journal-title":"J Neurochem"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib116","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nn1363","article-title":"Insulin signaling in the nervous system regulates ethanol intoxication in Drosophila melanogaster","volume":"8","author":"Corl","year":"2005","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1007\/s13311-019-00822-4_bib117","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1037\/a0012893","article-title":"Insulin receptor substrate-2 in the ventral tegmental area regulates behavioral responses to cocaine","volume":"122","author":"Iniguez","year":"2008","journal-title":"Behav Neurosci"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib118","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nn1812","article-title":"IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates","volume":"10","author":"Russo","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-019-00822-4_bib119","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neulet.2017.09.026","article-title":"Intranasal insulin treatment alleviates methamphetamine induced anxiety-like behavior and neuroinflammation","volume":"660","author":"Beirami","year":"2017","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib120","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/jcb.26398","article-title":"Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure","volume":"119","author":"Beirami","year":"2018","journal-title":"J Cell Biochem"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib121","doi-asserted-by":"crossref","first-page":"e16188","DOI":"10.1371\/journal.pone.0016188","article-title":"Insulin reduces neuronal excitability by turning on GABA(A) channels that generate tonic current","volume":"6","author":"Jin","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib122","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(03)02679-9","article-title":"Oliveira CRd. Insulin affects synaptosomal GABA and glutamate transport under oxidative stress conditions","volume":"977","author":"Duarte","year":"2003","journal-title":"Brain Res"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib123","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1471-4159.2004.02841.x","article-title":"Insulin exerts neuroprotection by counteracting the decrease in cell-surface GABAA receptors following oxygen\u2013glucose deprivation in cultured cortical neurons","volume":"92","author":"Mielke","year":"2005","journal-title":"J Neurochem"},{"issue":"6643","key":"10.1007\/s13311-019-00822-4_bib124","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/41792","article-title":"Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin","volume":"388","author":"Wan","year":"1997","journal-title":"Nature."},{"key":"10.1007\/s13311-019-00822-4_bib125","doi-asserted-by":"crossref","unstructured":"Trujeque-Ramos S, Castillo-Rol\u00f3n D, Galarraga E, Tapia D, Arenas-L\u00f3pez G, Mihailescu S, et al. Insulin Regulates GABAA Receptor-Mediated Tonic Currents in the Prefrontal Cortex. Front Neurosci. 2018;12(345).","DOI":"10.3389\/fnins.2018.00345"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib126","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nn.3321","article-title":"Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids","volume":"16","author":"Labou\u00e8be","year":"2013","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib127","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00702-004-0163-6","article-title":"Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt)","volume":"112","author":"Kim","year":"2005","journal-title":"J Neural Transm"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib128","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neubiorev.2010.04.008","article-title":"What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?","volume":"35","author":"Fernandez-Serrano","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"10.1007\/s13311-019-00822-4_bib129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cpr.2014.08.002","article-title":"Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment","volume":"34","author":"Schulte","year":"2014","journal-title":"Clin Psychol Rev"},{"key":"10.1007\/s13311-019-00822-4_bib130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neuropharm.2013.04.034","article-title":"Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment","volume":"76","author":"Ashare","year":"2014","journal-title":"Neuropharmacology."},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib131","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/adb.12029","article-title":"Withdrawal effect of chronic amphetamine exposure during adolescence on complex maze performance","volume":"19","author":"Krall","year":"2014","journal-title":"Addict Biol"},{"issue":"12","key":"10.1007\/s13311-019-00822-4_bib132","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00213-014-3840-7","article-title":"Memory impairment and alterations in prefrontal cortex gamma band activity following methamphetamine sensitization","volume":"232","author":"Janetsian","year":"2015","journal-title":"Psychopharmacology."},{"key":"10.1007\/s13311-019-00822-4_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nlm.2017.10.013","article-title":"Differential effects of MDMA and cocaine on inhibitory avoidance and object recognition tests in rodents","volume":"146","author":"Garc\u00eda-Pardo","year":"2017","journal-title":"Neurobiol Learn Mem"},{"key":"10.1007\/s13311-019-00822-4_bib134","doi-asserted-by":"crossref","unstructured":"Gobin C, Schwendt M. The effects of extended-access cocaine self-administration on working memory performance, reversal learning and incubation of cocaine-seeking in adult male rats. J Addict Prev. 2017;5(1).","DOI":"10.13188\/2330-2178.1000035"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0376-8716(93)90087-7","article-title":"Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence","volume":"32","author":"Berry","year":"1993","journal-title":"Drug Alcohol Depend"},{"key":"10.1007\/s13311-019-00822-4_bib136","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jsat.2017.08.002","article-title":"Attention and memory deficits in crack-cocaine users persist over four weeks of abstinence","volume":"81","author":"Almeida","year":"2017","journal-title":"J Subst Abus Treat"},{"issue":"5","key":"10.1007\/s13311-019-00822-4_bib137","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/ADM.0000000000000066","article-title":"Cocaine and cognition: a systematic quantitative review","volume":"8","author":"Potvin","year":"2014","journal-title":"J Addict Med"},{"issue":"5","key":"10.1007\/s13311-019-00822-4_bib138","first-page":"531","article-title":"Cognitive impairments in abstinent alcoholics","volume":"152","author":"Fein","year":"1990","journal-title":"West J Med"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib139","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1530-0277.1993.tb00750.x","article-title":"Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients","volume":"17","author":"Adams","year":"1993","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11065-007-9038-6","article-title":"Alcohol: effects on neurobehavioral functions and the brain","volume":"17","author":"Oscar-Berman","year":"2007","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib141","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/arclin\/act090","article-title":"Neurocognitive deficits, craving, and abstinence among alcohol-dependent individuals following detoxification","volume":"29","author":"Naim-Feil","year":"2013","journal-title":"Arch Clin Neuropsychol"},{"issue":"12","key":"10.1007\/s13311-019-00822-4_bib142","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1111\/ejn.12381","article-title":"Withdrawal from extended-access cocaine self-administration results in dysregulated functional activity and altered locomotor activity in rats","volume":"38","author":"Calipari","year":"2013","journal-title":"Eur J Neurosci"},{"issue":"23-24","key":"10.1007\/s13311-019-00822-4_bib143","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1007\/s00213-016-4421-8","article-title":"Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats","volume":"233","author":"Rao","year":"2016","journal-title":"Psychopharmacology."},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib144","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tins.2011.12.005","article-title":"The addicted brain craves new neurons: putative role for adult-born progenitors in promoting recovery","volume":"35","author":"Mandyam","year":"2012","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib145","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-014-3685-0","article-title":"Extended access nicotine self-administration with periodic deprivation increases immature neurons in the hippocampus","volume":"232","author":"Cohen","year":"2015","journal-title":"Psychopharmacology."},{"issue":"8","key":"10.1007\/s13311-019-00822-4_bib146","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00213-017-4566-0","article-title":"Adolescent cocaine exposure enhances goal-tracking behavior and impairs hippocampal cell genesis selectively in adult bred low-responder rats","volume":"234","author":"Garc\u00eda-Fuster","year":"2017","journal-title":"Psychopharmacology."},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib147","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/BPL-170058","article-title":"The role of hippocampal adult neurogenesis in methamphetamine addiction","volume":"3","author":"Takashima","year":"2018","journal-title":"Brain Plasticity"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib148","first-page":"323","article-title":"Long-lasting memory deficits in mice withdrawn from cocaine are concomitant with neuroadaptations in hippocampal basal activity, GABAergic interneurons and adult neurogenesis","volume":"10","author":"Ladr\u00f3n de Guevara-Miranda","year":"2017","journal-title":"Dis Model Mech"},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib149","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1073\/pnas.56.2.566","article-title":"Impaired and inadequate glucose metabolism in the brain as an underlying cause of alcoholism\u2013an hypothesis","volume":"56","author":"Roach","year":"1966","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1007\/s13311-019-00822-4_bib150","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.4877-14.2015","article-title":"Alcohol decreases baseline brain glucose metabolism more in heavy drinkers than controls but has no effect on stimulation-induced metabolic increases","volume":"35","author":"Volkow","year":"2015","journal-title":"J Neurosci"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib151","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11065-013-9228-3","article-title":"A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders","volume":"23","author":"Bates","year":"2013","journal-title":"Neuropsychol Rev"},{"issue":"8","key":"10.1007\/s13311-019-00822-4_bib152","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1176\/ajp.149.8.1016","article-title":"Decreased brain metabolism in neurologically intact healthy alcoholics","volume":"149","author":"Volkow","year":"1992","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1007\/s13311-019-00822-4_bib153","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1530-0277.2000.tb02061.x","article-title":"Regional brain metabolism during alcohol intoxication","volume":"24","author":"Wang","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib154","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0925-4927(90)90007-S","article-title":"Acute effects of ethanol on regional brain glucose metabolism and transport","volume":"35","author":"Volkow","year":"1990","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.186.1.8416587","article-title":"Functional importance of ventricular enlargement and cortical atrophy in healthy subjects and alcoholics as assessed with PET, MR imaging, and neuropsychologic testing","volume":"186","author":"Wang","year":"1993","journal-title":"Radiology."},{"issue":"8","key":"10.1007\/s13311-019-00822-4_bib156","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/sj.npp.1300453","article-title":"Acute alcohol effects on neuronal and attentional processing: striatal reward system and inhibitory sensory interactions under acute ethanol challenge","volume":"29","author":"Schreckenberger","year":"2004","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology."},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib157","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1530-0277.1990.tb00508.x","article-title":"Behavioral and subjective effects of ethanol: Relationship to cerebral metabolism using PET","volume":"14","author":"De Wit","year":"1990","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib158","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI65153","article-title":"Increased brain uptake and oxidation of acetate in heavy drinkers","volume":"123","author":"Jiang","year":"2013","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1007\/s13311-019-00822-4_bib159","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1017\/S0033291798006849","article-title":"Frontal dysfunction in neurologically normal chronic alcoholic subjects: metabolic and neuropsychological findings","volume":"28","author":"Dao-Castellana","year":"1998","journal-title":"Psychol Med"},{"issue":"10","key":"10.1007\/s13311-019-00822-4_bib160","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/jnnp.49.10.1165","article-title":"Local cerebral glucose utilisation in chronic alcoholics: a positron tomographic study","volume":"49","author":"Samson","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1007\/s13311-019-00822-4_bib161","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.410280608","article-title":"Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography","volume":"28","author":"Gilman","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-019-00822-4_bib162","doi-asserted-by":"crossref","unstructured":"Clergue-Duval V, Questel F, Azuar J, Paquet C, Cognat E, Amami J, et al. Brain 18FDG-PET pattern in patients with alcohol-related cognitive impairment. Eur J Nucl Med Mol Imaging 2019.","DOI":"10.1016\/j.fjpsy.2019.10.317"},{"issue":"11","key":"10.1007\/s13311-019-00822-4_bib163","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.neuropsychologia.2004.04.002","article-title":"Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex","volume":"42","author":"Goldstein","year":"2004","journal-title":"Neuropsychologia."},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib164","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4103\/ipj.ipj_26_18","article-title":"Frontal lobe executive dysfunction and cerebral perfusion study in alcohol dependence syndrome","volume":"26","author":"Khanna","year":"2017","journal-title":"Ind Psychiatry J"},{"issue":"9","key":"10.1007\/s13311-019-00822-4_bib165","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1177\/0271678X15611136","article-title":"Direct voxel-based comparisons between grey matter shrinkage and glucose hypometabolism in chronic alcoholism","volume":"36","author":"Ritz","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"issue":"11","key":"10.1007\/s13311-019-00822-4_bib166","doi-asserted-by":"crossref","first-page":"e7748","DOI":"10.1371\/journal.pone.0007748","article-title":"Morphological and glucose metabolism abnormalities in alcoholic Korsakoff's syndrome: group comparisons and individual analyses","volume":"4","author":"Pitel","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"10.1007\/s13311-019-00822-4_bib167","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0006-3223(91)90326-H","article-title":"PET in generalized anxiety disorder","volume":"29","author":"Wu","year":"1991","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib168","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/00001756-199703030-00048","article-title":"Cingulate function in depression: a potential predictor of treatment response","volume":"8","author":"Mayberg","year":"1997","journal-title":"Neuroreport."},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib169","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejrad.2007.02.006","article-title":"Altered default mode network activity in patient with anxiety disorders: an fMRI study","volume":"63","author":"Zhao","year":"2007","journal-title":"Eur J Radiol"},{"issue":"10","key":"10.1007\/s13311-019-00822-4_bib170","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","article-title":"Sugar for the brain: the role of glucose in physiological and pathological brain function","volume":"36","author":"Mergenthaler","year":"2013","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib171","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200317010-00003","article-title":"The role of insulin resistance in the pathogenesis of Alzheimer's disease","volume":"17","author":"Watson","year":"2003","journal-title":"CNS drugs."},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib172","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0167-0115(96)02120-9","article-title":"Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines","volume":"69","author":"Singh","year":"1997","journal-title":"Regul Pept"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib173","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0031-9384(04)00348-8","article-title":"Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans","volume":"83","author":"Stockhorst","year":"2004","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib174","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol"},{"issue":"1-4","key":"10.1007\/s13311-019-00822-4_bib176","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/00207459309003322","article-title":"The relationship between diabetes mellitus and Parkinson's disease","volume":"69","author":"Sandyk","year":"1993","journal-title":"Int J Neurosci"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib177","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic\u2013endocrine aspects in Huntington's disease","volume":"24","author":"Peters\u00e9n","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1007\/s13311-019-00822-4_bib178","doi-asserted-by":"crossref","first-page":"45971","DOI":"10.1038\/srep45971","article-title":"Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model","volume":"7","author":"Guo","year":"2017","journal-title":"Sci Rep"},{"issue":"20","key":"10.1007\/s13311-019-00822-4_bib179","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1523\/JNEUROSCI.1350-09.2009","article-title":"Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors","volume":"29","author":"Marks","year":"2009","journal-title":"J Neurosci"},{"issue":"6","key":"10.1007\/s13311-019-00822-4_bib180","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology."},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib181","doi-asserted-by":"crossref","first-page":"e2649","DOI":"10.1002\/hup.2649","article-title":"Learning and memory performance following acute intranasal insulin administration in abstinent smokers","volume":"33","author":"Hamidovic","year":"2018","journal-title":"Hum Psychopharmacol"},{"issue":"10","key":"10.1007\/s13311-019-00822-4_bib182","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/mp.2016.234","article-title":"Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial","volume":"22","author":"Hamidovic","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-019-00822-4_bib183","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3389\/fphar.2017.00706","article-title":"Targeting Mediators of Smoking Persistence with Intranasal Insulin","volume":"8","author":"Hamidovic","year":"2017","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib184","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuron.2012.09.026","article-title":"Stress-related neuropeptides and addictive behaviors: beyond the usual suspects","volume":"76","author":"Schank","year":"2012","journal-title":"Neuron."},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2005.01.008","article-title":"The role of insulin receptor signaling in the brain","volume":"16","author":"Plum","year":"2005","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1007\/s13311-019-00822-4_bib186","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0301-0082(91)90015-S","article-title":"Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects","volume":"36","author":"Unger","year":"1991","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1007\/s13311-019-00822-4_bib187","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1210\/en.2004-0607","article-title":"Insulin Alone Increases Hypothalamo-Pituitary-Adrenal Activity, and Diabetes Lowers Peak Stress Responses","volume":"146","author":"Chan","year":"2005","journal-title":"Endocrinology."},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib188","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1038\/sj.ijo.0801695","article-title":"Hyperinsulinemia causes activation of the hypothalamus-pituitary-adrenal axis in humans","volume":"25","author":"Fruehwald-Schultes","year":"2001","journal-title":"Int J Obes"},{"issue":"9","key":"10.1007\/s13311-019-00822-4_bib189","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1210\/jcem.84.9.5953","article-title":"Supraphysiological Hyperinsulinemia Acutely Increases Hypothalamic-Pituitary-Adrenal Secretory Activity in Humans","volume":"84","author":"Fruehwald-Schultes","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1007\/s13311-019-00822-4_bib190","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.psyneuen.2008.08.002","article-title":"Intranasal insulin attenuates the hypothalamic-pituitary-adrenal axis response to psychosocial stress","volume":"33","author":"Bohringer","year":"2008","journal-title":"Psychoneuroendocrinology."},{"issue":"2","key":"10.1007\/s13311-019-00822-4_bib191","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.ijo.0803722","article-title":"Obese men respond to cognitive but not to catabolic brain insulin signaling","volume":"32","author":"Hallschmid","year":"2008","journal-title":"Int J Obes"},{"issue":"17","key":"10.1007\/s13311-019-00822-4_bib192","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1523\/JNEUROSCI.20-17-06707.2000","article-title":"Disruption of Arcuate\/Paraventricular Nucleus Connections Changes Body Energy Balance and Response to Acute Stress","volume":"20","author":"Bell","year":"2000","journal-title":"J Neurosci"},{"issue":"20","key":"10.1007\/s13311-019-00822-4_bib193","doi-asserted-by":"crossref","first-page":"9048","DOI":"10.1523\/JNEUROSCI.22-20-09048.2002","article-title":"The Catabolic Action of Insulin in the Brain Is Mediated by Melanocortins","volume":"22","author":"Benoit","year":"2002","journal-title":"J Neurosci"},{"issue":"6","key":"10.1007\/s13311-019-00822-4_bib194","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1210\/endo.130.6.1597158","article-title":"Inhibition of hypothalamic neuropeptide Y gene expression by insulin","volume":"130","author":"Schwartz","year":"1992","journal-title":"Endocrinology."},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib195","first-page":"55","article-title":"How do glucocorticois influence stress responses- Integrating permissive, suppressive, stimulatory, and preparative actions","volume":"21","author":"Sapolsky","year":"2000","journal-title":"Endocr Rev"},{"issue":"6875","key":"10.1007\/s13311-019-00822-4_bib196","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/4151030a","article-title":"Functional neurogenesis in the adult hippocampus","volume":"415","author":"van Praag","year":"2002","journal-title":"Nature."},{"key":"10.1007\/s13311-019-00822-4_bib197","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fncel.2013.00005","article-title":"The therapeutic potential of endogenous hippocampal stem cells for the treatment of neurological disorders","volume":"7","author":"Taylor","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1007\/s13311-019-00822-4_bib198","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.2010.05896.x","article-title":"Hippocampus, amygdala and stress: interacting systems that affect susceptibility to addiction","volume":"1216","author":"Belujon","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"46","key":"10.1007\/s13311-019-00822-4_bib199","doi-asserted-by":"crossref","first-page":"11785","DOI":"10.1523\/JNEUROSCI.3798-08.2008","article-title":"Adult neurogenesis, mental health, and mental illness: hope or hype?","volume":"28","author":"Eisch","year":"2008","journal-title":"J Neurosci"},{"issue":"1","key":"10.1007\/s13311-019-00822-4_bib200","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1523\/JNEUROSCI.4256-09.2010","article-title":"Reduction of adult hippocampal neurogenesis confers vulnerability in an animal model of cocaine addiction","volume":"30","author":"Noonan","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00822-4_bib201","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neubiorev.2016.03.030","article-title":"A place for the hippocampus in the cocaine addiction circuit: Potential roles for adult hippocampal neurogenesis","volume":"66","author":"Castilla-Ortega","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"issue":"1-3","key":"10.1007\/s13311-019-00822-4_bib202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","article-title":"Glucose metabolism and insulin receptor signal transduction in Alzheimer disease","volume":"490","author":"Hoyer","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1007\/s13311-019-00822-4_bib203","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/db14-0568","article-title":"Insulin action in brain regulates systemic metabolism and brain function","volume":"63","author":"Kleinridders","year":"2014","journal-title":"Diabetes."},{"issue":"1-3","key":"10.1007\/s13311-019-00822-4_bib204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.02.047","article-title":"Insulin-like growth factor-I, cognition and brain aging","volume":"490","author":"van Dam","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-019-00822-4_bib205","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fnins.2019.00788","article-title":"Brain Insulin Resistance and Hippocampal Plasticity: Mechanisms and Biomarkers of Cognitive Decline","volume":"13","author":"Spinelli","year":"2019","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1007\/s13311-019-00822-4_bib206","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1471-4159.2005.03269.x","article-title":"Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner","volume":"94","author":"van der Heide","year":"2005","journal-title":"J Neurochem"},{"issue":"9","key":"10.1007\/s13311-019-00822-4_bib207","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.2337\/dc12-1437","article-title":"The effect of insulin infusion on the metabolites in cerebral tissues assessed with proton magnetic resonance spectroscopy in young healthy subjects with high and low insulin sensitivity","volume":"36","author":"Karczewska-Kupczewska","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1007\/s13311-019-00822-4_bib208","doi-asserted-by":"crossref","unstructured":"Guthoff M, Grichisch Y, Canova C, Tschritter O, Veit R, Hallschmid M, et al. Insulin Modulates Food-Related Activity in the Central Nervous System. J Clin Endocrinol Metab 2009.","DOI":"10.1210\/endo.151.1.9997"},{"key":"10.1007\/s13311-019-00822-4_bib209","doi-asserted-by":"crossref","unstructured":"Jauch-Chara K, Friedrich A, Rezmer M, Melchert UH, H GS-E, Hallschmid M, et al. Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans. Diabetes. 2012;61(9):2261-8.","DOI":"10.2337\/db12-0025"},{"issue":"6","key":"10.1007\/s13311-019-00822-4_bib210","doi-asserted-by":"crossref","first-page":"e39830","DOI":"10.1371\/journal.pone.0039830","article-title":"Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study","volume":"7","author":"Moreno-L\u00f3pez","year":"2012","journal-title":"PLoS One"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00822-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-019-00822-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923013818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923013818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00822-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:56:18Z","timestamp":1761807378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923013818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":210,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1878747923013818"],"URL":"https:\/\/doi.org\/10.1007\/s13311-019-00822-4","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal Insulin: a Treatment Strategy for Addiction","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-019-00822-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}